Exploring Novel Quinoline-1,3,4-Oxadiazole Derivatives for Alzheimer’s Disease: Their Design, Synthesis, and In-Vitro and In-Silico Investigations
Overall, this research contributes to the development of 1,3,4-oxadiazole- quinoline hybrids as potential AChE inhibitors for the treatment of Alzheimer's disease.
Authors
- Asaf Evrim Evren (ORCID: https://orcid.org/0000-0002-8651-826X)
- Begüm Nurpelin Sağlık (ORCID: https://orcid.org/0000-0002-0151-6266)
- Leyla Yurttaş (ORCID: https://orcid.org/0000-0002-0957-6044)
- Sana Saffour (ORCID: https://orcid.org/0000-0001-8124-9315)
Institutions
- Anadolu University (TR)
- Bilecik Şeyh Edebali Üniversitesi (TR)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2024-08-29
- DOI
- https://doi.org/10.2174/0109298673333159240815061359
- Citations
- 9
- Primary Topic
- Synthesis and biological activity
- Type
- article
- Field-Weighted Citation Impact
- 2.25